[Dementia induced by antianxiety drugs].
Inada
Ken
K
Department of Psychiatry, Kitasato University School of Medicine.
Ishigooka
Jun
J
D000375:Aging; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D002712:Chlorides / Q000378:metabolism; D003704:Dementia / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D058785:GABA-A Receptor Agonists; D006207:Half-Life; D006801:Humans; D054833:Isoindoles; D008569:Memory Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000517:prevention & control; D010879:Piperazines; D011743:Pyrimidines; D012307:Risk Factors; D017366:Serotonin Receptor Agonists; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D014151:Anti-Anxiety Agents; D002712:Chlorides; D058785:GABA-A Receptor Agonists; D054833:Isoindoles; D010879:Piperazines; D011743:Pyrimidines; D017366:Serotonin Receptor Agonists; D001569:Benzodiazepines; C055267:tandospirone; D005680:gamma-Aminobutyric Acid